低危初产妇期待管理至足月后的母婴结局
该研究为多中心随机试验的二次分析,纳入2502例接受期待管理的低危初产妇,按分娩孕周39、40、41-42周分组。结果显示,随孕周增加,医学指征引产率和剖宫产率显著上升,妊娠期高血压疾病减少,围产期复合结局无显著差异。
要点
- 期待管理中,39至42周剖宫产率从17.3%升至37.5%。
- 41-42周剖宫产调整相对风险为1.93(95%CI 1.61-2.32)。
- 围产期复合结局随孕周增加无显著差异。
核心结论
- 在期待管理的低危初产妇中,从39至42周,医学指征引产频率和剖宫产风险显著增加,但围产期复合结局无显著变化。
研究设计与样本
- 多中心随机试验的二次分析,纳入2502例接受期待管理且至少达到39 0/7周的低危初产妇。
主要发现
- 剖宫产率在39、40、41-42周分别为17.3%、22.0%、37.5%(P<.001)。
- 围产期复合结局在39、40、41-42周分别为5.1%、5.9%、8.2%(P=.03)。
- 妊娠期高血压疾病在39、40、41-42周分别为16.4%、12.1%、10.8%(P=.001)。
- 医学指征分娩率整体为37.9%,从39周的23.8%升至41-42周的80.3%。
关键数值与推荐
- 以39周为参照,41-42周剖宫产的调整相对风险为1.93(95%CI 1.61-2.32)。
- 以39周为参照,40周妊娠期高血压疾病的调整相对风险为0.71(95%CI 0.58-0.88)。
- 以39周为参照,41-42周妊娠期高血压疾病的调整相对风险为0.61(95%CI 0.45-0.82)。
临床怎么用
- 对于低危初产妇,期待管理至41-42周时剖宫产风险显著增加,需与患者充分沟通。
- 期待管理过程中应监测妊娠期高血压疾病,但随孕周增加其风险下降。
局限性
- 本研究为二次分析,结果需谨慎解释。
- 仅纳入接受期待管理且达到39周及以上的低危初产妇,外推性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare risks of maternal and perinatal outcomes by completed week of gestation from 39 weeks in low-risk nulliparous patients undergoing expectant management. METHODS: We conducted a secondary analysis of a multicenter randomized trial of elective induction of labor at 39 weeks of gestation compared with expectant management in low-risk nulliparous patients. Participants with nonanomalous neonates, who were randomized to and underwent expectant management and attained 39 0/7 weeks of gestation, were included. Delivery gestation was categorized by completed week: 39 0/7-39 6/7 (39 weeks), 40 0/7-40 6/7 (40 weeks), and 41 0/7-42 2/7 (41-42 weeks) (none delivered after 42 2/7). The coprimary outcomes were cesarean delivery and a perinatal composite (death, respiratory support, 5-minute Apgar score 3 or less, hypoxic ischemic encephalopathy, seizure, sepsis, meconium aspiration syndrome, birth trauma, intracranial or subgaleal hemorrhage, or hypotension requiring vasopressor support). Other outcomes included a maternal composite (blood transfusion, surgical intervention for postpartum hemorrhage, or intensive care unit admission), hypertensive disorders of pregnancy, peripartum infection, and neonatal intermediate or intensive care unit admission. For multivariable analysis, P<.0125 was considered to indicate statistical significance for the coprimary outcomes. RESULTS: Of 2,502 participants who underwent expectant management, 964 (38.5%) delivered at 39 weeks of gestation, 1,111 (44.4%) at 40 weeks, and 427 (17.1%) at 41-42 weeks. The prevalence of medically indicated delivery was 37.9% overall and increased from 23.8% at 39 weeks of gestation to 80.3% at 41-42 weeks. The frequency of cesarean delivery (17.3%, 22.0%, 37.5%; P<.001) and the perinatal composite (5.1%, 5.9%, 8.2%; P=.03) increased with 39, 40, and 41-42 weeks of gestation, respectively, and hypertensive disorders of pregnancy decreased (16.4%, 12.1%, 10.8%, P=.001). The adjusted relative risk, 95% CI (39 weeks as referent) was significant for cesarean delivery at 41-42 weeks of gestation (1.93, 1.61-2.32) and for hypertensive disorders of pregnancy at 40 weeks (0.71, 0.58-0.88) and 41-42 weeks (0.61, 0.45-0.82). None of the other outcomes were significant. CONCLUSION: In expectantly managed low-risk nulliparous participants, the frequency of medically indicated induction of labor, and the risks of cesarean delivery but not the perinatal composite outcome, increased significantly from 39 to 42 weeks of gestation.
引用
- Tita ATN, Doherty L, Grobman WA, et al. Maternal and Perinatal Outcomes of Expectant Management of Full-Term, Low-Risk, Nulliparous Patients. Obstet Gynecol. 2021. PMID: 33416294. doi:10.1097/AOG.0000000000004230
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。